Rivaroxaban
Showing 1 - 25 of 674
Atrial Fibrillation, Anticoagulant Adverse Reaction, Stroke Trial (low-dose rivaroxaban, Standard-dose rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- +3 more
- low-dose rivaroxaban
- Standard-dose rivaroxaban
- (no location specified)
Oct 25, 2023
Atrial Fibrillation, Coronary Artery Disease Trial (Rivaroxaban)
Not yet recruiting
- Atrial Fibrillation
- Coronary Artery Disease
- Rivaroxaban
- (no location specified)
Oct 22, 2023
Post Coronary Bypass Surgery Patients Trial in Shiraz (Rivaroxaban and aspirin 80, Aspirin 80)
Completed
- Post Coronary Bypass Surgery Patients
- Rivaroxaban and aspirin 80
- Aspirin 80
-
Shiraz, Fars, Iran, Islamic Republic ofProfessor Kojuri Cardiology Clinic
Sep 1, 2023
Atrial Fibrillation Trial in Xi'an (Rivaroxaban 15mg, Aspirin 100mg, Clopidogrel 75mg)
Recruiting
- Atrial Fibrillation
- Rivaroxaban 15mg
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 24, 2023
Left Ventricular Thrombus Trial in Peshawar (Warfarin, Rivaroxaban 20 MG Oral Tablet, Apixaban 5mg or 2.5mg oral tablet)
Recruiting
- Left Ventricular Thrombus
- Warfarin
- +2 more
-
Peshawar, KPK, PakistanPeshawar Institute of Cardiology
Jul 25, 2023
Healthy Volunteer Trial in Leeds (Aspirin, rivaroxaban low dose, rivaroxaban high dose)
Recruiting
- Healthy Volunteer
- Aspirin
- +2 more
-
Leeds, West Yorkshire, United KingdomLabCorp CRU
Jan 24, 2023
Acute Coronary Syndrome Trial (rivaroxaban)
Not yet recruiting
- Acute Coronary Syndrome
- rivaroxaban
- (no location specified)
Feb 20, 2023
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023
Hypothermia and Acidosis on Coagulation During Treatment With
Recruiting
- Trauma
- +3 more
- Rivaroxaban 15 MG
-
Lund, Skåne, SwedenSkåne University Hospital
Dec 30, 2022
Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease Trial in Seoul (Rivaroxaban 2.5mg)
Recruiting
- Atherosclerosis of Artery
- +3 more
- Rivaroxaban 2.5mg
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 2, 2023
Rivaroxaban and Apixaban in Cancer Patients
Recruiting
- Anticoagulants and Thrombotic Disorders
- Monitoring
-
Paris, FranceCentre d'Investigation Clinique Hôpital Pitié-Salpêtrière
Apr 20, 2023
Learn About Venous Thromboembolism Treatment With Rivaroxaban in
Completed
- Treatment of Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY59-7939)
-
Japan Databases, Japan
- +1 more
Jan 10, 2023
Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,
Not yet recruiting
- Kawasaki Disease
- +4 more
- Rivaroxaban Oral Tablet or Suspension [Xarelto]
- +2 more
- (no location specified)
Dec 6, 2022
Ischemic Stroke, Intracranial Atherosclerosis, Stenosis Trial (Rivaroxaban, Clopidogrel, Aspirin)
Not yet recruiting
- Ischemic Stroke
- +2 more
- Rivaroxaban
- +3 more
- (no location specified)
Jan 17, 2023
Bariatric Surgery Trial in Baden, Berne, Bern (Rivaroxaban 10 MG Oral Tablet [Xarelto])
Active, not recruiting
- Bariatric Surgery
- Rivaroxaban 10 MG Oral Tablet [Xarelto]
-
Baden, Switzerland
- +2 more
Dec 14, 2022
Atrial Fibrillation, Acute Coronary Syndrome Trial in Ottawa (Ticagrelor, Rivaroxaban)
Active, not recruiting
- Atrial Fibrillation
- Acute Coronary Syndrome
- Ticagrelor
- Rivaroxaban
-
Ottawa, Ontario, CanadaUniversity of Ottawa Heart Institute
Jan 12, 2023
Different Doses of Rivaroxaban in Elderly Chinese Nonvalvular
Not yet recruiting
- Atrial Fibrillation
- (no location specified)
Dec 5, 2022
Safety of Rivaroxaban in Children Under 2 Years Old With Venous
Not yet recruiting
- Venous Thromboembolism
- Children Under 2 Years
- Rivaroxaban (Xarelto, BAY59-7939)
- Standard of care (SOC)
-
Multiple Locations, Denmark
- +3 more
Jun 9, 2023
Atrial Fibrillation and Heart Failure Who Are ReceivingDirect
Completed
- Heart Failure
- Rivaroxaban (Xarelto, BAY59-7939)
-
Multiple Locations, SpainMany Locations
Dec 29, 2022
Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction Trial in Tehran (Rivaroxaban 15 MG, Warfarin)
Recruiting
- Left Ventricular Thrombus
- ST Segment Elevation Myocardial Infarction
- Rivaroxaban 15 MG
- Warfarin
-
Tehran, Iran, Islamic Republic of
- +1 more
Jan 21, 2023
Left Ventricular Thrombus, Myocardial Infarction Trial (Rivaroxaban, Warfarin)
Not yet recruiting
- Left Ventricular Thrombus
- Myocardial Infarction
- Rivaroxaban
- Warfarin
- (no location specified)
Mar 31, 2023
Patient With Anterior Myocardial Infarction Trial in Sohag (-group of patients(75 patients) will receive low dose rivaroxaban
Not yet recruiting
- Patient With Anterior Myocardial Infarction
- -group of patients(75 patients) will receive low dose rivaroxaban myocardial infarction plus (acetylsalicylic acid 75 mg and clopidogrel 75 mg
- (acetylsalicylic acid 75 mg once daily orally and clopidogrel 75 mg once daily orally only)
-
Sohag, EgyptSohag University Hospital
Feb 16, 2023
Venous Thromboembolism, Anticoagulant-induced Bleeding, Venous Thromboses Trial in Metepec (Rivaroxaban 20 MG [Xarelto], Aspirin
Completed
- Venous Thromboembolism
- +3 more
- Rivaroxaban 20 MG [Xarelto]
- +2 more
-
Metepec, Estado De Mexico, MexicoInstituto Mexicano Del Seguro Social
Aug 24, 2022
Dose Optimization of Rivaroxaban Combined With Rifampicin
Recruiting
- Infections
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 17, 2022